Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Ritlecitinib is an effective new treatment for Alopecia Areata.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Androgen receptor overexpression can increase prostate cancer cell growth even without hormones.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The right amount of retinoic acid is essential for normal hair growth and development.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Prenatal retinoic acid exposure did not affect mouse vibrissal follicle development.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.